Pravastatin
A statin.
General information
Pravastatin is used for hypercholesteremia treatment. It has also immunomodulatory properties (NCIt).
Pravastatin on DrugBank
Pravastatin on PubChem
Pravastatin on Wikipedia
Marketed as
ELISOR; LIPOSTAT; MEVALOTIN; PRAVASELECT; PRAVACHOL; PRAVASTATIN; PRAVASTATIN SODIUM; SELIPRAN
CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O
Supporting references
| Link | Tested on | Impact factor | Notes | Publication date |
|---|---|---|---|---|
|
In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19
|
Patients | 21.57 | A retrospective cohort study of in-hospital statin use among COVID-19 patients. Lower risk of all-cause mortality. Lower use of invasive mechanical ventilation, ARDS prevalence and ICU admission. Possible due to inflammatory response amelioration. Dosage - daily equivalent dose of statin, median 20 mg. Endpoints - 28-day all-cause mortality; ICU admission; use of invasive mechanical ventilation; ARDS incidence. Sample size 16 patients (1,219 statins + 12,762 control). |
Aug/04/2020 |
